Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Syncona Share Price
  4. Syncona Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksSyncona Share News (SYNC)

Syncona Information

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.00
Bid: 121.20
Ask: 122.00
Change: 1.60 (1.33%)
Spread: 0.80 (0.66%)
Open: 121.00
High: 122.00
Low: 120.40
Prev. Close: 120.40
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 04th Nov 2021 16:05

Friday 5 November 
4imprint Group PLCTrading Statement
Beazley PLCTrading Statement
International Consolidated Airlines Group SAQ3 Results
River & Mercantile Group PLCFull Year Results
Monday 8 November 
Argentex Group PLCHalf Year Results
Cake Box Holdings PLCHalf Year Results
Dignity PLCQ3 Results
DX Group PLCFull Year Results
Kosmos Energy LtdFull Year Results
Sirius Real Estate LtdHalf Year Results
Ultra Electronics Holdings PLCQ3 Results
Tuesday 9 November 
Alfa Financial Software Holdings PLCTrading Statement
Associated British Foods PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
DCC PLCHalf Year Results
Direct Line Insurance Group PLCTrading Statement
Genedrive PLCFull Year Results
Grafton Group PLCTrading Statement
Meggitt PLCTrading Statement
Oxford Instruments PLCHalf Year Results
Persimmon PLCTrading Statement
Renewi PLCHalf Year Results
Shepherd Neame LtdFull Year Results
Warehouse REIT PLCHalf Year Results
Watches of Switzerland Group PLCQ3 Results
Wednesday 10 November 
Aveva Group PLCHalf Year Results
Bowleven PLCFull Year Results
Glanbia PLCTrading Statement
Grafton Group PLCTrading Statement
Halfords Group PLCHalf Year Results
ITV PLCTrading Statement
JD Wetherspoon PLCTrading Statement
Marks & Spencer Group PLCHalf Year Results
Picton Property Income LtdHalf Year Results
Renold PLCHalf Year Results
S4 Capital PLCTrading Statement
Tracsis PLCFull Year Results
Vistry Group PLCTrading Statement
Zoo Digital Group PLCHalf Year Results
Thursday 11 November 
3i Group PLCHalf Year Results
Assura PLCHalf Year Results
Auto Trader Group plcHalf Year Results
Aviva PLCTrading Statement
B&M European Value Retail SAHalf Year Results
Bank of Georgia Group PLCQ3 Results
Burberry Group PLCHalf Year Results
Endeavour Mining CorpQ3 Results
Great Eastern Energy Corp LtdHalf Year Results
Manolete Partners PLCHalf Year Results
Mediclinic International PLCHalf Year Results
Norcros PLCHalf Year Results
OSB Group PLCTrading Statement
QinetiQ Group PLCHalf Year Results
Regional REIT PLCTrading Statement
Spirent Communications PLCTrading Statement
Syncona LtdHalf Year Results
Taylor Wimpey PLCTrading Statement
Ted Baker PLCHalf Year Results
Tremor International LtdQ3 Results
Urban Logistics REIT PLCHalf Year Results
Vesuvius PLCTrading Statement
Volex PLCHalf Year Results
WH Smith PLCFull Year Results
Young & Co's Brewery PLCHalf Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
11 Apr 2024 14:22

Syncona agrees to sell stake in investee company for GBP7.4 million

(Alliance News) - Syncona Ltd on Thursday said it has reached an agreement to sell one of its portfolio companies to US biotechnology firm, Century Therapeutics Inc.

Read more
4 Apr 2024 17:06

IN BRIEF: Syncona notes investee Achilles's annual loss narrows

Syncona Ltd - London-based investor in healthcare companies - Notes that the loss of investee and clinical-stage biopharmaceutical company Achilles Therapeutics PLC narrows by 2.7% to USD68.2 million in 2023 from USD71.1 million in 2022. General and administrative costs contract by 19% to USD17.0 million from USD21.1 million. According to Syncona's website, the company has a 25% stake in Achilles.

Read more
14 Mar 2024 14:16

Syncona portfolio company Autolus posts widened loss for 2023

(Alliance News) - Syncona Ltd on Thursday noted the 2023 results of one of its life science portfolio companies, which showed a widened loss and an increase in annual expenses.

Read more
12 Feb 2024 18:01

IN BRIEF: Freeline shareholders approve Syncona acquisition

Syncona Ltd - London-based investor in healthcare companies - Freeline Therapeutics Holdings PLC shareholders approve acquisition by Syncona.

Read more
8 Feb 2024 13:45

UPDATE: Syncona portfolio strengthens thanks to Autolus

(Alliance News) - Syncona Ltd on Thursday said its portfolio company Autolus Therapeutics PLC has struck a deal to work with BioNTech to commercialise its CAR-T programmes.

Read more
8 Feb 2024 09:41

Syncona portfolio strengthens in third quarter thanks to Autolus

(Alliance News) - Syncona Ltd on Thursday reported a recent increase to the value of its portfolio, as the company said it was in a strong position to push forward its main life science companies.

Read more
8 Feb 2024 09:04

Syncona NAV grows in Q3

(Sharecast News) - Life sciences investor Syncona said on Thursday that its net asset value had grown in the three months ended 31 December, driven by a prioritisation of capital allocation across its portfolio to enable the delivery of key inflection points.

Read more
22 Jan 2024 12:19

IN BRIEF: Syncona notes FDA acceptance of Autolus's BLA for obe-cel

Syncona Ltd - London-based investor in healthcare companies - The US Food & Drug Administration accepts Autolus Therapeutics PLC's biologics licence application for obe-cel for patients with relapsed/refractory adult B-cell acute lymphoblastic leukaemia. The FDA has set a target action date of November 16 for reviewing the application, Syncona says. Further, Autolus is on track to submit a marketing authorisation application to the EU's European Medicines Agency in the first half of 2024.

Read more
19 Jan 2024 08:36

Syncona says Freeline trial for Gaucher disease treatment positive

(Alliance News) - Syncona Ltd on Friday noted Freeline Therapeutics Holdings PLC's positive data for Gaucher disease treatment.

Read more
4 Dec 2023 09:37

IN BRIEF: Syncona notes Beacon's "encouraging" AGTC-501 trial data

Syncona Ltd - London-based investor in healthcare companies - Says portfolio company, Beacon Therapeutics has presented three-month data from the phase 2 Skyline trial of its viral vector-based gene therapy AGTC-501 in X-linked retinitis pigmentosa at the Floretina ICOOR 2023 Congress in Rome. Notes AGTC-501 shows an "encouraging efficacy profile", showing a "significant improvement" in retinal sensitivity. Adds that there are no clinically significant safety events related to AGTC-501.

Read more
27 Nov 2023 19:03

TRADING UPDATES: Molten Ventures completes raise; Saietta proposes one

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
22 Nov 2023 14:30

IN BRIEF: Syncona agrees to buyout deal with Freeline Therapeutics

Syncona Ltd - London-based investor in healthcare companies - Agrees to acquire all remaining stock in investee Freeline Therapeutics Holdings PLC for USD6.50 in cash per share, valuing Freeline at approximately USD28.3 million. Syncona currently owns 49.7% of shares in Freeline. The company will provide up to USD15 million of financing in conjunction with the acquisition to enable Freeline to meet its near-term cash requirements and continue advancing its lead programme FLT201, a potential gene therapy for Gaucher disease.

Read more
16 Nov 2023 10:34

Syncona reports declining asset value as investment head steps down

(Alliance News) - Syncona Ltd on Thursday said net asset value decreased as it swung to a negative return in its latest half year, but that it is well-positioned for future growth thanks to its "rich pipeline".

Read more
16 Nov 2023 08:44

Syncona net asset value falls, co-founder steps down

(Sharecast News) - Life science specialist Syncona reported a net asset value of £1.2bn at the end of its first half on Thursday, down from £1.25bn on 31 March, with a net asset value return of -4.2% during the period.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.